Cargando…

Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis

PURPOSE: The Oncotype DX© 21-gene Recurrence Score (RS) estimates the risk of distant disease recurrence in early-stage estrogen receptor-positive, human epidermal growth factor receptor-2-negative (ER+/HER2− ) breast cancer. Using RS to estimate risk of locoregional recurrence (LRR) is less conclus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, Matthew G., Cleere, Eoin F., O’Donnell, John P., Gaisor, Sara, Lowery, Aoife J., Kerin, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114034/ https://www.ncbi.nlm.nih.gov/pubmed/35426541 http://dx.doi.org/10.1007/s10549-022-06580-w

Ejemplares similares

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Radiomic Detection of Malignancy within Thyroid Nodules Using Ultrasonography—A Systematic Review and Meta-Analysis
por: Cleere, Eoin F., et al.
Publicado: (2022)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
por: Kerin, Eoin P., et al.
Publicado: (2022)

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis
por: Davey, M.G., et al.
Publicado: (2021)

Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis
por: Lu, Yujie, et al.
Publicado: (2021)

Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials
por: Davey, Matthew G., et al.
Publicado: (2022)

Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
por: Davey, Matthew G., et al.
Publicado: (2021)

MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

Evaluating the Clinical Utility of Routine Sentinel Lymph Node Biopsy and the Value of Adjuvant Chemotherapy in Elderly Patients Diagnosed With Oestrogen Receptor Positive, Clinically Node Negative Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2021)

General data protection regulations (2018) and clinical research: perspectives of patients and doctors in an Irish university teaching hospital
por: Davey, Matthew G., et al.
Publicado: (2021)

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
por: Davey, Matthew G., et al.
Publicado: (2021)

Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences
por: Priedigkeit, Nolan, et al.
Publicado: (2021)

Optimal primary wound closure methods after thyroid and parathyroid surgery: network meta-analysis of randomized clinical trials
por: Davey, Matthew G, et al.
Publicado: (2023)

Breast cancer recurrence: factors impacting occurrence and survival
por: Courtney, Donald, et al.
Publicado: (2022)

Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer
por: Yang, David D., et al.
Publicado: (2020)

Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up
por: Turashvili, Gulisa, et al.
Publicado: (2018)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
por: Davey, Matthew G, et al.
Publicado: (2022)

Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review
por: Ding, Jingxian, et al.
Publicado: (2020)

Multiple nodal locoregional recurrence of pheochromocytoma
por: Ramírez-Plaza, César Pablo, et al.
Publicado: (2015)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab
por: McGuire, Andrew, et al.
Publicado: (2017)

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©
por: Davey, Matthew G., et al.
Publicado: (2022)

Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Dysregulated miR-183 inhibits migration in breast cancer cells
por: Lowery, Aoife J, et al.
Publicado: (2010)

Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety
por: O’Halloran, Niamh, et al.
Publicado: (2017)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023)

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
por: Stemmer, Salomon M., et al.
Publicado: (2013)

Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
por: de Jong, Mees Hendrik Siert, et al.
Publicado: (2022)

Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy
por: Kandula, Shravan, et al.
Publicado: (2015)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
por: Kheradmand, Ali Arab, et al.
Publicado: (2010)

Risk Factors of the Invasive Breast Cancer Locoregional Recurrence
por: Liubota, R. V., et al.
Publicado: (2015)

The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer
por: Kim, Tae Hyun, et al.
Publicado: (2010)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
por: Liu, Hongjia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_trqm1spr7nqv30agvb5fbk1sk2